bpc 157 for ulcerative colitis FDA panel backs compounded BPC-157, KPV peptides in win RFK Jr FDA's own advisory committee voted

FDA's own advisory committee voted 8 6 Thursday. BPC 157, on the compounding list now, for ulcerative colitis. FDA staff argued against it, laid out the data gaps, the whole case. Panel overruled them Is the lack of human data in BPC 157 a red flag?, , If a drug could actually knit torn tendons back together in weeks, a trillion dollar pharmaceutical industry probably wouldnt bury itthey Post from Dr. Jones, DC YouTube A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! Most FDA advisers say peptides like BPC 157 and TB 500 should be made available in the U.S. Here's what happens next. MarketWatch

SKU: 9592064593 · From hgidocs.co